enGene Therapeutics Inc. Warrants (ENGNW)
enGene Therapeutics Inc. Warrants (ENGNW) has a 10-report earnings history dating back to Mar 11, 2024. Its average absolute post-earnings move is ±11.43%, and 100.0% of those reactions were positive. Its largest post-earnings gain was +114.29% (Jun 15, 2026) and its largest decline was +0% (Mar 09, 2026). The next earnings report is predicted for 2026-09-10 (estimated).
Earnings reactions
How ENGNW moved on each past earnings report.
Earnings Impact
Total Earnings
10
Avg Abs. Movement
±11.43%
Positive %
100.0%
Negative %
0.0%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Jun 15, 2026 | ☀ PRE | +114.29% | open_in_new |
| Mar 09, 2026 | ☀ PRE | +0% | open_in_new |
| Dec 22, 2025 | ☽ POST | +0% | open_in_new |
| Sep 11, 2025 | ☽ POST | +0% | open_in_new |
Earnings Count
10
Total earnings in dataset
Avg Abs. Movement
±11.43%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 3 | 20260722 | open_in_new SEC.gov |
| 3 | 20260722 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260722 | open_in_new SEC.gov |
| 8-K | 20260717 | open_in_new SEC.gov |
| 8-K | 20260716 | open_in_new SEC.gov |
| 8-K/A | 20260618 | open_in_new SEC.gov |
| 4 | 20260617 | open_in_new SEC.gov |
| 4 | 20260617 | open_in_new SEC.gov |
| 4 | 20260617 | open_in_new SEC.gov |
| 4 | 20260617 | open_in_new SEC.gov |
Frequently asked about ENGNW earnings
When does enGene Therapeutics Inc. Warrants report earnings next? expand_more
enGene Therapeutics Inc. Warrants (ENGNW)'s next earnings date is estimated for 2026-09-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does ENGNW stock move after earnings? expand_more
Over 10 reports, ENGNW has moved an average of ±11.43% the session after earnings, closing higher 100.0% of the time.
What was ENGNW's biggest post-earnings move? expand_more
ENGNW's largest post-earnings gain on record was +114.29% on Jun 15, 2026, and its largest decline was +0% on Mar 09, 2026.
Where can I find enGene Therapeutics Inc. Warrants's SEC filings? expand_more
All of enGene Therapeutics Inc. Warrants's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right